The Profile of Lung Adenocarcinoma Patients with Positive EGFR Mutation
Green Medical Journal · 2020
DOI: 10.33096/gmj.v2i1.37 ↗Kurz gefasst
Fachartikel in der Zeitschrift Green Medical Journal, 2020. Verfasst von Edward Pandu Wiriansya und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Background
The high mortality rate in pulmonary carcinoma is a problem encountered in various countries, including Indonesia. According to WHO, there are 2.09 million people affected by lung cancer and 1.76 million deaths due to lung cancer worldwide. This study was aimed to determine the profile of lung adenocarcinoma patients with positive EGFR mutation.
Methods
The study was descriptive study with cross-sectional approach using secondary data obtained from medical records of lung adenocarcinoma patients.
Results
The present study revealed that lung adenocarcinoma was found higher in patients with age >40 years old (93.9%) compared to those with age
Zitieren
APA
Wiriansya, E. P., Ainun, Ratu, P., & Noor, A. M. R. C. (2020). The Profile of Lung Adenocarcinoma Patients with Positive EGFR Mutation. Green Medical Journal. https://doi.org/10.33096/gmj.v2i1.37
Vancouver
Wiriansya EP, Ainun, Ratu P, Noor AMRC. The Profile of Lung Adenocarcinoma Patients with Positive EGFR Mutation. Green Medical Journal. 2020. doi:10.33096/gmj.v2i1.37
BibTeX
@article{Wiriansya2020,
author = {Wiriansya, Edward Pandu and Ainun and Ratu, Puspa and Noor, Andi Muhammad Reza Cesarian},
title = {The Profile of Lung Adenocarcinoma Patients with Positive EGFR Mutation},
journal = {Green Medical Journal},
year = {2020},
doi = {10.33096/gmj.v2i1.37}
}
EUVIMED